bibliographic resource 1721311 [br/1721311]
https://w3id.org/oc/corpus/br/1721311

is a

• document
• article

title

• Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial

publication date

• 2010-01-01

contributor

• https://w3id.org/oc/corpus/ar/6047775
• https://w3id.org/oc/corpus/ar/6047776
• https://w3id.org/oc/corpus/ar/6047777
• https://w3id.org/oc/corpus/ar/6047778
• https://w3id.org/oc/corpus/ar/6047779
• https://w3id.org/oc/corpus/ar/6047780
• https://w3id.org/oc/corpus/ar/6047781
• https://w3id.org/oc/corpus/ar/6047782
• https://w3id.org/oc/corpus/ar/6047783
• https://w3id.org/oc/corpus/ar/6047784
• https://w3id.org/oc/corpus/ar/6047785
• https://w3id.org/oc/corpus/ar/6047786
• https://w3id.org/oc/corpus/ar/6047787
• https://w3id.org/oc/corpus/ar/6047788

format

• https://w3id.org/oc/corpus/re/864335

identifier

• https://w3id.org/oc/corpus/id/3109995
• https://w3id.org/oc/corpus/id/3109996
• https://w3id.org/oc/corpus/id/3109997
• https://w3id.org/oc/corpus/id/3109998

part of

• https://w3id.org/oc/corpus/br/897922